Ibrutinib Plus Rituximab in Treatment-Naive Patients with Follicular Lymphoma: Results from a Multicenter, Phase 2 StudyNathan Fowler, M. Lia Palomba, Ian W. Flinn et al.|Blood|2015Cited by 35
The combination of ibrutinib and rituximab demonstrates activity in first‐line follicular lymphomaNathan Fowler, M. Lia Palomba, Loretta J. Nastoupil et al.|British Journal of Haematology|2020Cited by 28
Ibrutinib Combined with Rituximab in Treatment-Naive Patients with Follicular Lymphoma: Arm 1 + Arm 2 Results from a Multicenter, Open-Label Phase 2 StudyNathan Fowler, M. Lia Palomba, Loretta J. Nastoupil et al.|Blood|2016Cited by 9
A phase II trial of single-agent vinflunine as second-line treatment for advanced non-small cell lung cancer (An International Oncology Network Study, #I-05–009)M. Joppert, Cheryl Jones, Mark Knapp et al.|Journal of Clinical Oncology|2008Cited by 3